Mark S. Aikman Pharm.d.

Mark S. Aikman, Pharm.D. has a strong background in pharmaceutical regulatory affairs, with over 35 years of experience in the field. Mark S. is currently serving as the VP of Regulatory Affairs at Piramal Critical Care, a position they have held since 2023. Prior to this, Mark was the President of Reg-Tec, Inc., a consulting firm specializing in regulatory affairs, quality assurance, and operational consulting. Mark S. held this role from 2018 to 2023.

Before their time at Reg-Tec, Inc., Mark spent 16 years at Osmotica Pharmaceutical Corp., where they served as Vice President from 2002 to 2018. Earlier in their career, they held positions at Steris Laboratories as the Director of Regulatory Affairs, Schwarz Pharma as Manager of Regulatory Affairs, and Central Pharmaceuticals as Director of Regulatory Affairs. Mark's extensive experience in regulatory strategy, application submissions, quality audits, and understanding operational requirements make him a valuable asset in the pharmaceutical industry.

Mark S. Aikman, Pharm.D. completed their Bachelor of Science (BS) degree in Pharmacy from Butler University in 1979. Mark S. then pursued further education in the field of Pharmacy and obtained their Doctor of Pharmacy (Pharm.D.) degree from the University of Kentucky in 1990. It is also known that they have another Bachelor of Science (BS) degree in Pharmacy from Butler University, although the specific years of study for this degree are not provided.